Clinicopathological features and oncological outcomes of early and late recurrence in stage iii colorectal cancer patients after adjuvant oxaliplatin-based therapy

HIGHLIGHTS

• who: Yu-Tang Chang and colleagues from the Division of Pediatric Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan have published the paper: Clinicopathological Features and Oncological Outcomes of Early and Late Recurrence in Stage III Colorectal Cancer Patients after Adjuvant Oxaliplatin-Based Therapy, in the Journal: Journal of Oncology of 19/Oct/2022
• what: Of them, 162 patients were excluded because of the following reasons: 125 patients did not receive an adjuvant oxaliplatin-based regimen after surgery; 7 patients started receiving oxaliplatin-based therapy after recurrence; and 30 patients . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.